Supplementary Figure S3 from Targeting LAMP2A Enhances SELENBP1 Expression and Suppresses Malignant Behaviors in HNSCC

Figure S3. (A and B) To obtain stable clones after infections with sh1-LAMP2A or sh2-LAMP2A lentiviral vectors, cells were selected with puromycin for 5 days. Knockdown efficiency of LAMP2A was verified by qRT-PCR and Western blot. β-actin served as loading control. (C) Quantitative analysis of EdU+ cells. The representative images were shown in Figure 5C.